Skip to main content
. 2017 Jun 26;30(5):542–549. doi: 10.20524/aog.2017.0170

Figure 1.

Figure 1

Prevalence of several priorities for interferon-free regimens among study participants. Percentages on each bar are cumulative for all indications to the left

The last column does not reach 100% because there were 48 (9.6%) patients who could not be classified as the severity of liver fibrosis was not known.